136 related articles for article (PubMed ID: 33319857)
1. Distinct genomic profiles of gestational choriocarcinoma, a unique cancer of pregnant tissues.
Jung SH; Choi YJ; Kim MS; Park HC; Han MR; Hur SY; Lee AW; Shin OR; Kim J; Lee SH; Hong D; Song SY; Chung YJ; Lee SH
Exp Mol Med; 2020 Dec; 52(12):2046-2054. PubMed ID: 33319857
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
3. Genomic profile in gestational and non-gestational choriocarcinomas.
Mello JB; Ramos Cirilo PD; Michelin OC; Custódio Domingues MA; Cunha Rudge MV; Rogatto SR; Maestá I
Placenta; 2017 Feb; 50():8-15. PubMed ID: 28161066
[TBL] [Abstract][Full Text] [Related]
4. Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series.
Zhang X; Yan K; Chen J; Xie X
Diagn Pathol; 2019 Aug; 14(1):93. PubMed ID: 31421690
[TBL] [Abstract][Full Text] [Related]
5. Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese.
Zhang R; Wu Y; Wang X; Lu X; Li Y; Li S; Yan X
Int J Med Sci; 2020; 17(3):325-331. PubMed ID: 32132867
[No Abstract] [Full Text] [Related]
6. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
Savage J; Adams E; Veras E; Murphy KM; Ronnett BM
Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059
[TBL] [Abstract][Full Text] [Related]
7. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
[TBL] [Abstract][Full Text] [Related]
9. [Genetic genesis of choriocarcinoma].
Zhao J; Xiang Y; Wan XR; Feng FZ; Cui QC; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):35-40. PubMed ID: 20367924
[TBL] [Abstract][Full Text] [Related]
10. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.
Barresi V; Romano A; Musso N; Capizzi C; Consoli C; Martelli MP; Palumbo G; Di Raimondo F; Condorelli DF
Genes Chromosomes Cancer; 2010 Nov; 49(11):1014-23. PubMed ID: 20725993
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the copy-neutral loss of heterozygosity identified from whole-exome sequencing data using three different tools.
Lee GT; Chung YJ
Genomics Inform; 2022 Mar; 20(1):e4. PubMed ID: 35399003
[TBL] [Abstract][Full Text] [Related]
12. Somatic mosaicism for copy-neutral loss of heterozygosity and DNA copy number variations in the human genome.
Žilina O; Koltšina M; Raid R; Kurg A; Tõnisson N; Salumets A
BMC Genomics; 2015 Sep; 16(1):703. PubMed ID: 26376747
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of hydatidiform mole and choriocarcinoma.
Bracken MB; Brinton LA; Hayashi K
Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of DNA copy number alterations in early and advanced gastric cancers.
Arakawa N; Sugai T; Habano W; Eizuka M; Sugimoto R; Akasaka R; Toya Y; Yamamoto E; Koeda K; Sasaki A; Matsumoto T; Suzuki H
Mol Carcinog; 2017 Feb; 56(2):527-537. PubMed ID: 27312513
[TBL] [Abstract][Full Text] [Related]
15. Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group.
Xu X; Bryke C; Sukhanova M; Huxley E; Dash DP; Dixon-Mciver A; Fang M; Griepp PT; Hodge JC; Iqbal A; Jeffries S; Kanagal-Shamanna R; Quintero-Rivera F; Shetty S; Slovak ML; Yenamandra A; Lennon PA; Raca G
Cancer Genet; 2018 Dec; 228-229():218-235. PubMed ID: 30344013
[TBL] [Abstract][Full Text] [Related]
16. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss of the PTEN gene and mutation of the TP53 gene in choriocarcinoma arising from gastric adenocarcinoma: analysis of loss of heterozygosity in two male patients with extragonadal choriocarcinoma.
Tate G; Suzuki T; Nemoto H; Kishimoto K; Hibi K; Mitsuya T
Cancer Genet Cytogenet; 2009 Sep; 193(2):104-8. PubMed ID: 19665071
[TBL] [Abstract][Full Text] [Related]
18. Genetically homozygous choriocarcinoma following pregnancy with hydatidiform mole.
Fisher RA; Lawler SD; Povey S; Bagshawe KD
Br J Cancer; 1988 Dec; 58(6):788-92. PubMed ID: 2906253
[TBL] [Abstract][Full Text] [Related]
19. Ovarian choriocarcinoma arising from partial mole as evidenced by deoxyribonucleic acid microsatellite analysis.
Namba A; Nakagawa S; Nakamura N; Takazawa Y; Kugu K; Tsutsumi O; Taketani Y
Obstet Gynecol; 2003 Nov; 102(5 Pt 1):991-4. PubMed ID: 14672475
[TBL] [Abstract][Full Text] [Related]
20. Renal angiomyolipoma (AML) harboring a missense mutation of
Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
